Role of matrix metalloproteinase-10 in the BMP-2 inducing osteoblastic differentiation

Endocrine Journal

Volumn 60, Issue 12, 2013, Pages 1309-1319

  Mao, Li ^a   Yano, Masato ^a   Kawao, Naoyuki ^a   Tamura, Yukinori ^a   Okada, Kiyotaka ^a   Kaji, Hiroshi ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic protein; Fibrodysplasia ossificans progressiva; Matrix metalloproteinase 10; Muscle ossification; Osteoblast

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; COLLAGEN TYPE 1; OSTEOCALCIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; SMAD8 PROTEIN; SMALL INTERFERING RNA; STROMELYSIN 2; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; GENETIC TRANSFECTION; HETEROTOPIC OSSIFICATION; HUMAN; MOUSE; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFYING MYOSITIS; OSTEOBLAST; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

ACTIVIN RECEPTORS, TYPE I; AMINO ACID SUBSTITUTION; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; CELL DIFFERENTIATION; CELL LINE; COLLAGEN TYPE I; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MATRIX METALLOPROTEINASE 10; MICE; MUTANT PROTEINS; MYOBLASTS; OSTEOBLASTS; OSTEOCALCIN; RECOMBINANT PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD6 PROTEIN; SMAD7 PROTEIN; TRANSCRIPTION FACTORS;

EID: 84891466040     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ13-0270     Document Type: Article

References (37)

1. Shore EM, Kaplan FS (2008) Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP). Bone 43: 427-433.
2. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, et al. (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38: 525-527.
3. Fukuda T, Kohda M, Kanomata K, Nojima J, Nakamura A, et al. (2009) Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. J Biol Chem 284: 7149-7156.
4. Song GA, Kim HJ, Woo KM, Baek JH, Kim GS, et al. (2010) Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva. J Biol Chem 285: 22542-22553.
5. Tanaka K, Inoue Y, Hendy GN, Canaff L, Katagiri T, et al. (2012) Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells. Bone 51: 158-167.
6. Nishimura R, Kato Y, Chen D, Harris SE, Mundy GR, et al. (1998) Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem 273: 1872-1879.
7. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, et al. (1991) Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113: 681-687.
8. Bragdon B, Moseychuk O, Saldanha S, King D, Julian J, et al. (2011) Bone morphogenetic proteins: a critical review. Cell Signal 23: 609-620.
9. Milner JM, Cawston TE (2005) Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases. Curr Drug Targets Inflamm Allergy 4: 363-375.
10. Werner JA, Rathcke IO, Mandic R (2002) The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis 19: 275-282.
11. Bord S, Horner A, Hembry RM, Compston JE (1998) Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: Potential roles in skeletal development. Bone 23: 7-12.
12. Armstrong D, Phelps LN, Vincenti MP (2009) CCAAT enhancer binding protein-β regulates matrix metalloproteinase-1 expression in interleukin-1β-stimulated A549 lung carcinoma cells. Mol Cancer Res 7: 1517-1524.
13. Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69: 562-573.
14. Orbe J, Montero I, Rodriguez JA, Beloqui O, Roncal C, et al. (2007) Independent association of matrix metallo-proteinase-10, cardiovascular risk factors and subclinical atherosclerosis. J Thromb Haemost 5: 91-97.
15. Orbe J, Rodriguez JA, Calvayrac O, Rodriguez-Calvo R, Rodriguez C, et al. (2009) Matrix metalloproteinase-10 is upregulated by thrombin in endothelial cells and increased in patients with enhanced thrombin generation. Arterioscler Thromb Vasc Biol 29: 2109-2116.
16. Orbe J, Barrenetxe J, Rodriguez JA, Vivien D, Orset C, et al. (2011) Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism. Circulation 124: 2909-2919.
17. Kawao N, Tamura Y, Okumoto K, Yano M, Okada K, et al. (2013) Plasminogen plays a crucial role in bone repair. J Bone Miner Res 28: 1561-1574.
18. Tamura Y, Kawao N, Okada K, Yano M, Okumoto K, et al. (2013) Plasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice. Diabetes 62: 3170-3179.
19. Tanaka K, Matsumoto E, Higashimaki Y, Katagiri T, Sugimoto T, et al. (2012) Role of osteoglycin in the linkage between muscle and bone. J Biol Chem 287: 11616-11628.
20. Komosinska-Vassev K, Olczyk P, Winsz-Szczotka K, Kuznik-Trocha K, Klimek K, et al (2011) Age-and gender-dependent changes in connective tissue remodeling: physiological differences in circulating MMP-3, MMP-10, TIMP-1 and TIMP-2 level. Gerontology 57: 44-52.
21. Harada H, Tagashira S, Fujiwara M, Ogawa S, Katsumata T, et al. (1999) Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 274: 6972-6978.
22. Wodarz A, Nusse R (1998) Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14: 59-88.
23. Hisa I, Inoue Y, Hendy GN, Canaff L, Kitazawa R, et al. (2011) Parathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathway. J Biol Chem 286: 9787-9796.
24. Martignetti JA, Aqeel AA, Sewairi WA, Boumah CE, Kambouris M, et al. (2001) Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 28: 261-265.
25. Inoue K, Mikuni-Takagaki Y, Oikawa K, Itoh T, Inada M, et al. (2006) A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism. J Biol Chem 281: 33814-33824.
26. Kennedy AM, Inada M, Krane SM, Christie PT, Harding B, et al. (2005) MMP13 mutation causes spondyloepimetaphyseal dysplasia, Missouri type (SEMD(MO). J Clin Invest 115: 2832-2842.
27. Inada M, Wang Y, Byrne MH, Rahman MU, Miyaura C, et al. (2004) Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci U S A 101: 17192-17197.
28. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, et al. (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411-422.
29. Holmbeck K, Bianco P, Chrysovergis K, Yamada S, Birkedal-Hansen H (2003) MT1-MMP-dependent, apoptotic remodeling of unmineralized cartilage: a critical process in skeletal growth. J Cell Biol 163: 661-671.
30. Haeusler G, Walter I, Helmreich M, Egerbacher M (2005) Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation. Calcif Tissue Int 76: 326-335.
31. Somerville RP, Oblander SA, Apte SS (2003) Matrix metalloproteinases: old dogs with new tricks. Genome Biol 4: 216.
32. Fang J, Hall BK (1997) Chondrogenic cell differentiation from membrane bone periostea. Anat Embryol (Berl) 196: 349-362.
33. Komori T (2002) Runx2, a multifunctional transcription factor in skeletal development. J Cell Biochem 87: 1-8.
34. Stein GS, Lian JB, van Wijnen AJ, Stein JL, Montecino M, et al. (2004) Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 23: 4315-4329.
35. Pizette S, Niswander L (2000) BMPs are required at two steps of limb chondrogenesis: formation of prechondrogenic condensations and their differentiation into chondrocytes. Dev Biol 219: 237-249.
36. Sun J, Kamei CN, Layne MD, Jain MK, Liao JK, et al. (2001) Regulation of myogenic terminal differentiation by the hairy-related transcription factor CHF2. J Biol Chem 276: 18591-18596.
37. Bentmann A, Kawelke N, Moss D, Zentgraf H, Bala Y, et al. (2010) Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function. J Bone Miner Res 25: 706-715.